Vaccine Development from the Pathologist Perspective
Friday, August 28
Co-Chairs: Rani Sellers, DVM, PhD, DACVP, Pfizer Inc.; and Cynthia Rohde, PhD, Pfizer Inc.
The design and execution of toxicology studies supporting vaccine development have several unique elements relative to the conduct of traditional small molecule- or monoclonal antibody-supporting studies. This course is designed to give an overview of vaccine development, with emphasis on the regulatory guidances and special considerations in vaccine development (prophylactic and therapeutic), study design (including species selection), unique technical considerations, and anatomic and clinical pathology findings.
Introduction to Vaccine Developments
Cynthia M. Rohde, PhD, DABT, Pfizer Inc.
Animal Models to Support Vaccine Development
Rani Sellers, DVM, PhD, DACVP, Pfizer Inc.
Points to Consider in Vaccine Study Design and Implementation
Keith G. Nelson, DVM, PhD, DACVP, Charles River Laboratories
Anatomic and Clinical Pathology Interpretation and Correlations
Niraj K. Tripathi, BVSc, MVSc, PhD, DACVP, Covance; and Bindu Bennet, DVM, MSc, MS, PhD, Voyager Therapeutics
Determining Adversity: Contributions of Local Tolerance, Acute Phase Reactants, and Systemic Reactivity
Registration View More Courses